Carolyn M. Carpenedo
Johns Hopkins University School of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Carolyn M. Carpenedo.
Journal of Substance Abuse Treatment | 2012
Kimberly C. Kirby; Carolyn M. Carpenedo; Maxine L. Stitzer; Karen L. Dugosh; Nancy M. Petry; John M. Roll; Michael E. Saladin; Allan J. Cohen; John A. Hamilton; Karen Reese; Gina R. Sillo; Patricia Quinn Stabile; Robert C. Sterling
This study empirically examined opinions of treatment providers regarding contingency management (CM) programs while controlling for experience with a specific efficacious CM program. In addition to empirically describing provider opinions, we examined whether the opinions of providers at the sites that implemented the CM program were more positive than those of matched providers at sites that did not implement it. Participants from 7 CM treatment sites (n = 76) and 7 matched nonparticipating sites (n = 69) within the same nodes of the National Institute of Drug Abuse Clinical Trials Network completed the Provider Survey of Incentives (PSI), which assesses positive and negative beliefs about incentive programs. An intent-to-treat analysis found no differences in the PSI summary scores of providers in CM program versus matched sites, but correcting for experience with tangible incentives showed significant differences, with providers from CM sites reporting more positive opinions than those from matched sites. Some differences were found in opinions regarding costs of incentives, and these generally indicated that participants from CM sites were more likely to see the costs as worthwhile. The results from the study suggest that exposing community treatment providers to incentive programs may itself be an effective strategy in prompting the dissemination of CM interventions.
Substance Use & Misuse | 2007
Carolyn M. Carpenedo; Mick Needham; Todd W. Knealing; Kenneth Kolodner; Michael Fingerhood; Conrad J. Wong; Kenneth Silverman
This study assesses the frequency that users of illicit drugs display unprofessional behaviors in an employment setting. This research was conducted in the therapeutic workplace, a model employment-based treatment program for chronically unemployed adults with long histories of illicit drug use in 2003. Fifty-three unemployed adults in methadone treatment, who were opiate and cocaine dependent, showed signs of injection drug use, and recently used cocaine were hired to work for 4 hours every weekday for 7 months. Results show that while the overall incidence of many undesirable behaviors is low, a small percentage of participants had serious workplace behavior problems that might limit their success in community workplaces. This study suggests that unprofessional behavior in the workplace could contribute to chronic unemployment in this population. The studys limitations are noted and future needed research is suggested.
Drug and Alcohol Dependence | 2013
Kimberly C. Kirby; Carolyn M. Carpenedo; Karen L. Dugosh; Beth J. Rosenwasser; Lois A. Benishek; Alicia Janik; Rachel Keashen; Elena Bresani; Kenneth Silverman
BACKGROUND This is the first study to systematically manipulate duration of voucher-based reinforcement therapy (VBRT) to see if extending the duration increases abstinence during and following VBRT. METHODS We randomized cocaine-dependent methadone-maintained adults to Standard (12 weeks; n=62) or Extended (36 weeks; n=68) VBRT and provided escalating voucher amounts contingent upon urinalysis verification of cocaine abstinence. Urinalysis was scheduled at least every 2 weeks during the 48-week study and more frequently during VBRT (3/week) and 12 weeks of Aftercare (2/week). RESULTS Extended VBRT produced longer durations of continuous cocaine abstinence during weeks 1-24 (5.7 vs 2.7 weeks; p=0.003) and proportionally more abstinence during weeks 24-36 (X(2)=4.57, p=.03, OR=2.18) compared to Standard VBRT. Duration of VBRT did not directly predict after-VBRT abstinence; but longer continuous abstinence during VBRT predicted abstinence during Aftercare (p=0.001) and during the last 12 weeks of the study (p<0.001). Extended VBRT averaged higher monthly voucher costs compared to Standard VBRT (
American Journal of Health Behavior | 2010
Carolyn M. Carpenedo; Kimberly C. Kirby; Karen L. Dugosh; Beth J. Rosenwasser; D. L. Thompson
96 vs
Psychology of Addictive Behaviors | 2017
Kimberly C. Kirby; Lois A. Benishek; MaryLouise E. Kerwin; Karen L. Dugosh; Carolyn M. Carpenedo; Elena Bresani; James A. Haugh; Yukiko Washio; Robert J. Meyers
43, p<.001); however, the average cost per week of abstinence attained was higher in the Standard group (
Journal of Substance Abuse Treatment | 2016
Adam C. Brooks; Jaclyn E. Chambers; Jennifer Lauby; Elizabeth Byrne; Carolyn M. Carpenedo; Lois A. Benishek; Rachel Medvin; David S. Metzger; Kimberly C. Kirby
8.06 vs
Journal of Substance Abuse Treatment | 2010
Brian Versek; Carolyn M. Carpenedo; Beth J. Rosenwasser; Karen L. Dugosh; Elena Bresani; Kimberly C. Kirby
5.88, p<.001). Participants in the Extended group with voucher costs exceeding
Journal of Applied Behavior Analysis | 2008
Kimberly C. Kirby; MaryLouise E. Kerwin; Carolyn M. Carpenedo; Beth J. Rosenwasser; Robert S. Gardner
25 monthly averaged 20 weeks of continuous abstinence. CONCLUSIONS Greater abstinence occurred during Extended VBRT, but providing a longer duration was not by itself sufficient to maintain abstinence after VBRT. However, if abstinence can be captured and sustained during VBRT, then providing longer durations may help increase the continuous abstinence that predicts better long-term outcomes.
Journal of Substance Abuse Treatment | 2012
Adam C. Brooks; Graham DiGuiseppi; Alexandre B. Laudet; Beth J. Rosenwasser; Dan Knoblach; Carolyn M. Carpenedo; Deni Carise; Kimberly C. Kirby
OBJECTIVE To determine whether longer durations of voucher-based reinforcement therapy (VBRT) increase long-term abstinence compared to standard durations. METHODS Cocaine-abusing or dependent methadone-maintenance patients (N = 130) were randomized to receive either Standard (12-week; n = 62) or Extended (36-week; n = 68) VBRT. Participants provided 3 urine samples weekly during VBRT, and each cocaine-negative sample produced a voucher exchangeable for goods and services. RESULTS Extended VBRT produced longer durations of self-reported continuous abstinence during study Year 1 (M = 74 vs. 46 days; F(1,128) = 5.23, P = 0.024), but not during Year 2. However, each week of abstinence during Year 1 was associated with an increase of 9.19 days of abstinence during Year 2, regardless of study condition (t(1) = 4.92, P < 0.001). CONCLUSIONS Longer-duration VBRT can increase abstinence during VBRT, but may not maintain it afterwards. However, longer during-treatment abstinence begets later abstinence suggesting that further research regarding this relationship is needed.
Drug and Alcohol Dependence | 2014
Adam C. Brooks; Alexandre B. Laudet; T. Case; Carolyn M. Carpenedo; Daniel J. Knoblach; Lois A. Benishek; Deni Carise; Kimberly C. Kirby
Community Reinforcement and Family Training (CRAFT) assists family members with a treatment-resistant loved one. The most consistent outcome of CRAFT is increased treatment entry of the identified treatment-resistant person (IP). This led us to question whether all 6 components of CRAFT are necessary. In a randomized clinical trial, 115 concerned significant others (CSOs) of an IP received 12–14 sessions of the full CRAFT intervention, 4–6 sessions focused on Treatment Entry Training (TEnT), or 12–14 sessions of Al-Anon/Nar-Anon Facilitation (ANF). We monitored treatment entry, attendance, and substance use of the IP and the CSO’s mood and functioning. Data were collected at baseline and 4, 6, and 9 months after the baseline. We found significant reductions in time to treatment entry (&khgr;(2)2 = 8.89, p = .01) and greater treatment entry rates for CRAFT (62%; odds ratio [OR] = 2.7, 95% confidence interval [CI] = 1.1–6.9) and TEnT (63%; OR = 2.9, 95% CI = 1.2–7.5) compared with ANF (37%), but CRAFT and TEnT did not differ significantly from each other (OR = 1.1, 95% CI = 0.4–2.7). No between-group differences in IP drug use were reported by CSOs, but days of drug use decreased over time for all groups (F(3, 277) = 13.47, p < .0001). Similarly, CSO mood and functioning did not differ between the 3 conditions but improved over time (p < .0001 for all significant measures). We replicated the results of previous trials demonstrating that CRAFT produces greater treatment entry rates than ANF and found similar treatment entry rates for CRAFT and TEnT. This suggests that treatment entry training is sufficient for producing the best established outcome of CRAFT.